Article    Table of Contents                    Full Text of this article Free    PDF of this article    Summary for Patients    Summary for Patients (PDF)    Figures/Tables List    Related articles in Annals  Services    Send comment/rapid response letter    Notify a friend about this article    Alert me when this article is cited    Add to Personal Archive    Download to Citation Manager    ACP Search    Get Permissions  Google Scholar    Search for Related Content  Social Bookmarking

What's this?

PubMed

Related Articles in PubMed    PubMed Citation    PubMed

CLINICAL GUIDELINES

Routine Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Primary Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement

U.S. Preventive Services Task Force*

6 March 2007 | Volume 146 Issue 5 | Pages 361-364

This statement summarizes the U.S. Preventive Services Task Force (USPSTF) recommendation and supporting scientific evidence on routine use of aspirin or nonsteroidal anti-inflammatory drugs for the primary prevention of colorectal cancer. The complete information on which this statement is based, including evidence tables and references, is available in the accompanying articles in this issue and on the USPSTF Web site (http://www.preventiveservices.ahrq.gov).

The USPSTF is redesigning its recommendation statement in response to feedback from primary care clinicians. The USPSTF plans to release, later in 2007, a new, updated recommendation statement that is easier to read and incorporates advances in USPSTF methodology. The recommendation statement below is an interim version that combines existing language and elements with a new format. Although the definitions of grades remain the same, other elements have been revised.

*For a list of the members of the U.S. Preventive Services Task Force, see the Appendix.

Author and Article Information

From the U.S. Preventive Services Task Force, Agency for Healthcare Research and Quality, Rockville, Maryland.

Disclaimer: Recommendations made by the USPSTF are independent of the U.S. government. They should not be construed as an official position of the Agency for Healthcare Research and Quality or the U.S. Department of Health and Human Services.

Requests for Single Reprints: Reprints are available from the USPSTF Web site (www.preventiveservices.ahrq.gov) and in print through the Agency for Healthcare Research and Quality Publications Clearinghouse (800-358-9295).

CiteULike

Complore

Connotea

Del.icio.us

Digg

Facebook

Reddit

Technorati

Twitter

Find additional patient-related information at:

Federal Panel: Don\'t Use Pain Relievers to Guard Against Colon Cancer

Related articles in Annals:

Clinical Guidelines
The Use of Aspirin for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force
Catherine Dubé, Alaa Rostom, Gabriela Lewin, Alexander Tsertsvadze, Nicholas Barrowman, Catherine Code, Margaret Sampson, AND David Moher

Annals 2007 146: 365-375. [ABSTRACT][SUMMARY][Full Text]  

Clinical Guidelines
Nonsteroidal Anti-inflammatory Drugs and Cyclooxygenase-2 Inhibitors for Primary Prevention of Colorectal Cancer: A Systematic Review Prepared for the U.S. Preventive Services Task Force
Alaa Rostom, Catherine Dubé, Gabriela Lewin, Alexander Tsertsvadze, Nicholas Barrowman, Catherine Code, Margaret Sampson, AND David Moher

Annals 2007 146: 376-389. [ABSTRACT][SUMMARY][Full Text]  

Summaries for Patients
Aspirin or Nonsteroidal Anti-inflammatory Drugs for the Prevention of Colorectal Cancer: U.S. Preventive Services Task Force Recommendations

Annals 2007 146: I-35. [Full Text]  

This article has been cited by other articles:

				J. Burn, D. T. Bishop, J.-P. Mecklin, F. Macrae, G. Moslein, S. Olschwang, M.-L. Bisgaard, R. Ramesar, D. Eccles, E. R. Maher, et al. Effect of Aspirin or Resistant Starch on Colorectal Neoplasia in the Lynch Syndrome N. Engl. J. Med., December 11, 2008; 359(24): 2567 - 2578. [Abstract] [Full Text] [PDF]

				R. S. Sandler Aspirin Should Not Be Promoted for Colon Cancer Prevention: Counterpoint Cancer Epidemiol. Biomarkers Prev., July 1, 2008; 17(7): 1562 - 1563. [Full Text] [PDF]

				R. Logan Commentary: Preventing colorectal cancer with aspirin what next? Int. J. Epidemiol., October 5, 2007; (2007) dym204v1. [Full Text] [PDF]

				J. Guirguis-Blake, N. Calonge, T. Miller, A. Siu, S. Teutsch, E. Whitlock, and for the U.S. Preventive Services Task Force Current Processes of the U.S. Preventive Services Task Force: Refining Evidence-Based Recommendation Development Ann Intern Med, July 17, 2007; 147(2): 117 - 122. [Abstract] [Full Text] [PDF]

				USPSTF Recommends Against Routine Aspirin or NSAIDs to Prevent Colorectal Cancer Journal Watch (General), March 27, 2007; 2007(327): 2 - 2. [Full Text]